Clinical Trial Update: Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on ULSC for facioscapulohumeral muscular dystrophy, highlighting safety assessments and preliminary efficacy signals with ongoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy

Drugs mentioned

• ULSC

Snippet

Sponsor: Restem, LLC. | Conditions: FSHD - Facioscapulohumeral Muscular Dystrophy | Phase 1 | Status: RECRUITING